Influences of Cigarette-Smoke on Pharmaokinetics
香烟烟雾对药代动力学的影响
基本信息
- 批准号:05671898
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Influences of acute exposure to smoke of cigarette smoke and nicotine administration on pharmacokinetics of orally administered phenobarbital, primidone, and indomethacin were investigated in rats.First, we developed a method of simultaneously determinig primidone and its active metabolote, phenylethylmalonamide (PEMA), in rat plasma by HPLC usiung a solid-phase extraction technique.Second, using above new method, primidone and its metabolite, PEMA,concentration in plasma were determined when primidone was adminstered to the rat exposed to cigarette smoke, i.e., resulting in lower primidone and PEMA concentration. Furthermore phenobarbital and indomethacin plasma concetrations in exposed group to cigarette smoke were lower than those in the non-smoking control group. The degree of influences of exposure to cigarette smoke was proportional to the content of nicotine in the cigarette smoke.On the other hand, effects of nicotine administration on pharmacokinetics of primidone, phenobarbital and indomethacin were almost the same result in the cigarette-smoke experiments.
本文研究了急性吸烟和尼古丁暴露对大鼠口服苯巴比妥、扑米酮和吲哚美辛药代动力学的影响。首先,我们建立了固相萃取-高效液相色谱法同时测定大鼠血浆中扑米酮及其代谢物苯乙基丙二酰胺(PEMA)的方法。其次,我们应用该方法测定了扑米酮及其代谢物苯乙基丙二酰胺(PEMA)的浓度。当扑米酮给药于暴露于香烟烟雾的大鼠时,即,导致扑米酮和PEMA浓度降低。吸烟组苯巴比妥和吲哚美辛的血浆浓度低于不吸烟对照组。香烟烟雾暴露的影响程度与香烟烟雾中尼古丁的含量成正比,而尼古丁对扑米酮、苯巴比妥和吲哚美辛药代动力学的影响与香烟烟雾暴露的结果基本一致。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masahiro MORIYAMA,et al: "Simultaneous determination of primidone and its active metabolites in rat plasma by high-performance liquid chromatography using a solid-phase extraction technique" Journal of Pharmaceutical Sciences. 83. 1751-1753 (1994)
Masahiro MORIYAMA 等人:“使用固相萃取技术通过高效液相色谱同时测定大鼠血浆中扑米酮及其活性代谢物”《药物科学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
MASAHIRO MORIYAMA: "Stimultaneous determination of primidone and its active metabolites in rat plasma by high-performance liquid chromatography using a solid-phase extraction technique" Journal of Pharmaceuticol Sciences. 83. 1751-1753 (1994)
MASAHIRO MORIYAMA:“使用固相萃取技术通过高效液相色谱法同时测定大鼠血浆中扑米酮及其活性代谢物”《药剂科学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
MASAHIRO MORIYAMA: "Stimul taneous determination of primidone and its active metabolites in rat plasme by high-performance liguid chromatogra using a solid-phase exfvace in fechnigue" Journal of Pharmaceutical Sciences. 83. 1751-1753 (1994)
MASAHIRO MORIYAMA:“使用 Fechnigue 中的固相萃取装置通过高性能液体色谱刺激测定大鼠血浆中的扑米酮及其活性代谢物”《药物科学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GOMITA Yutaka其他文献
GOMITA Yutaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GOMITA Yutaka', 18)}}的其他基金
Individual therapy due to CYP genetic polymorphisms in patient with epilepsy
CYP基因多态性癫痫患者的个体化治疗
- 批准号:
17590123 - 财政年份:2005
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Influences of Various Emotional Situations on Pharmaokinetics and Pharmacodynamics
各种情绪状况对药代动力学和药效学的影响
- 批准号:
09672325 - 财政年份:1997
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Influence of stress on pharmacokinetics of various drugs
应激对多种药物药代动力学的影响
- 批准号:
02671053 - 财政年份:1990
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Pharmacokinetics-Based DNA-Encoded Library Screening
基于药代动力学的 DNA 编码文库筛选
- 批准号:
10644211 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Clinical pharmacokinetics and pharmacodynamics of antiseizure medications in special populations with epilepsy
抗癫痫药物在癫痫特殊人群中的临床药代动力学和药效学
- 批准号:
23K06250 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Clinical investigation on factors affecting pharmacokinetics for the individual dosing design of orexin receptor antagonists
食欲素受体拮抗剂个体化给药设计影响药代动力学因素的临床研究
- 批准号:
23K06237 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inner ear pharmacokinetics and development of drug delivery systems targeting the inner ear barrier mechanism
内耳药代动力学和针对内耳屏障机制的药物递送系统的开发
- 批准号:
23K08952 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)
肺结核 (COOK TB) 中空洞和肉芽肿导向的炎症和组织药代动力学
- 批准号:
10568147 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
A STUDY TO ASSESS EFFICACY, SAFTETY AND PHARMACOKINETICS OF EYU688 IN HEALTHY PARTICIPANTS CHALLENGED WITH DENGUE SEROTYPE 2
评估 EYU688 对患有登革热血清型 2 的健康参与者的功效、安全性和药代动力学的研究
- 批准号:
10925568 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Formulation and pharmacokinetics of subcutaneous administration of deferiprone for prevention of chronic heart failure following hemorrhagic myocardial infarction.
皮下注射去铁酮预防出血性心肌梗死后慢性心力衰竭的配方和药代动力学。
- 批准号:
10700370 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
EPCTU: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Tuberculosis
EPCTU:一项评估结核病治疗药物的药代动力学和安全性的研究
- 批准号:
10912971 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别: